NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Equity Markets Remain Among the Most Expensive in the World

Despite a sharp correction in the Indian equity markets, valuations continue to tell a different story. The Nifty has fallen 10 percent so far in 2026, while the Nifty 500 index has lost 5.4 percent. However, despite this underperformance relative to global peers, Indian stocks remain among the most expensive in the world.

According to Bloomberg data, the Nifty 500 index, which accounts for nearly 90 percent of India's total listed market capitalisation, has 151 stocks - or 30 percent of the index - trading above 50 times trailing twelve-month price-to-earnings multiples. This is higher than the 148 stocks at such elevated valuations when Indian markets hit their peak in September 2024. At the broader 30 times trailing PE threshold, nearly 52 percent of Nifty 500 stocks currently trade above that level, compared with 54 percent in September 2024.

The picture is even starker within the benchmark Nifty 50. Currently, 14 stocks - or 28 percent of the index - trade above 50 times trailing PE, against 11 stocks at the end of September 2024. At the 30 times threshold, the figure stands at 37 percent today, compared with 30 percent then.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

In contrast, many global indices have rallied sharply over the same period, yet carry far fewer richly valued names. The S&P 500, which has gained over 7 percent so far in 2026, currently has just 50 stocks - 10 percent of its constituents - trading above 50 times trailing PE, up from 27 stocks or around 5 percent at the end of September 2024.

IndexStocks above 50x PEStocks above 30x PE
S&P 50050 (10%)150 (30%)
Nasdaq239 (7%)450 (12%)
Nifty 500151 (30%)255 (52%)
Nifty 5014 (28%)18 (37%)

European markets reflect an even more moderate picture. The UK's FTSE 100 has 6 percent of its stocks above 50 times trailing PE, Germany's DAX stands at 13 percent, and France's CAC 40 at just 2.5 percent. Notably, both the FTSE 100 and the CAC 40 had zero stocks above that threshold at the end of September 2024, while the DAX had just five. At the 30 times level, the FTSE 100 has 15 percent of its stocks above that mark, while the CAC 40 and DAX each stand at around 5 percent.

Across Asia, where markets have surged in recent months, valuations have risen but remain more moderate than India's. China's Shanghai Composite now has 25 percent of its stocks above 50 times trailing PE, up sharply from 5 percent at the end of September 2024, while at the 30 times threshold the figure stands at 37 percent compared with 30 percent previously.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

IndexStocks above 50x PEStocks above 30x PE
Shanghai Composite25%37%
Taiex (Taiwan)11%17%
Kospi (South Korea)8%15%

Analysts are divided on what the numbers mean for investors. Saurabh Jain, Head of Fundamental Research at SMC Global Securities, said India's equity valuations continue to raise concern even after the recent correction, particularly in the broader market. He warned that sustained earnings disappointment, persistent macro pressures, or continued foreign selling could trigger a sharper de-rating in richly valued segments.

Veteran investor Prashant Jain offered a more measured reading, stating that valuations across sectors have become more balanced following the correction seen over the last two years. He added that multiples had fallen to reasonable levels after correction in both prices and time, and that there are no deeply undervalued sectors.

Investor Takeaway

Investors should be cautious of overvalued Indian stocks despite the global market correction.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.